TGFBR2 and pachyonychia congenita: TCGA dataset analysis shows that genetic alterations in TGF-β signaling are represented in about 30% of GI tumor specimens; in particular, mutations of TGFBR2 and SMAD4 are common in PC and colorectal cancers (CRCs) (Table 1) [2].